Cel Sci (CVM) Buildings (2015 - 2016)
Cel Sci (CVM) posted Buildings of $21.2 million for Q3 2016, little changed sequentially from $21.2 million in Q3 2015, and little changed YoY from $21.2 million in Q4 2015.
Cel Sci (CVM) Buildings (2015 - 2016) Analysis & Trends
Cel Sci has reported Buildings for 2 years, with the latest figure at $21.2 million in Q3 2016.
- Quarterly Buildings changed 0.0% year-over-year to $21.2 million in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $21.2 million (changed 0.0% YoY) and the FY2016 annual result came in at $21.2 million, changed 0.0% from the prior year.
- Buildings was little changed at $21.2 million in Q3 2016 per CVM's latest filing, from $21.2 million in the prior quarter.
- Over five years, Buildings peaked at $21.2 million in Q3 2015 and troughed at $21.2 million in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 21.18 Mn |
| Sep 30, 2015 | 21.18 Mn |